Poseida Therapeutics, Inc. (61) | Business Operations (1)
- Collaboration Agreements (1 contract)
- Collaboration and License Agreement, by and between the Registrant and Takeda Pharmaceuticals USA, Inc., effective October 11, 2021 (Filed With SEC on March 10, 2022)
